1-7 of 7
Authors: Marc Heckmann
Save search
Sort by
Journal Article

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data Open Access

PDF
Nowell Solish and others
Aesthetic Surgery Journal, Volume 42, Issue 12, December 2022, Pages 1460–1469, https://doi.org/10.1093/asj/sjac210
Published: 04 August 2022
Journal Article

Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines Open Access

PDF
Benjamin Ascher and others
Aesthetic Surgery Journal, Volume 41, Issue 11, November 2021, Page 1338, https://doi.org/10.1093/asj/sjab111
Published: 19 March 2021
Journal Article

Response to “Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA PRO Guidance” Open Access

PDF
Benjamin Ascher and others
Aesthetic Surgery Journal, Volume 40, Issue 12, December 2020, Pages NP710–NP711, https://doi.org/10.1093/asj/sjaa240
Published: 22 September 2020
Journal Article
EDITOR'S CHOICE

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial Open Access

PDF
Benjamin Ascher and others
Aesthetic Surgery Journal, Volume 40, Issue 9, September 2020, Pages 1000–1008, https://doi.org/10.1093/asj/sjz248
Published: 24 September 2019
Journal Article

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients Open Access

PDF
Berthold-Josef Rzany and others
Aesthetic Surgery Journal, Volume 40, Issue 4, April 2020, Pages 413–429, https://doi.org/10.1093/asj/sjz110
Published: 05 April 2019
Journal Article
EDITOR'S CHOICE

Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines Open Access

PDF
Benjamin Ascher and others
Aesthetic Surgery Journal, Volume 40, Issue 1, January 2020, Pages 93–104, https://doi.org/10.1093/asj/sjz003
Published: 20 March 2019
Journal Article

Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial Get access

PDF
Benjamin Ascher and others
Aesthetic Surgery Journal, Volume 38, Issue 2, February 2018, Pages 183–191, https://doi.org/10.1093/asj/sjw272
Published: 14 February 2017